News • 21-9-2017

ESC GRAND DEBATE | Aspirin for life

ESC 2017 One of the ESC Grand Debates revolved around whether or not aspirin should be used for primary and/or secondary CV prevention. Yes, there is a lot of evidence, but how valid is that evidence? Read an impression of the debate. Read more
News • 16-9-2017

Six instead of three meals per day improves glucose control in obese people with diabetes

EASD 2017 Obese people with prediabetes or diabetes showed better glucose control and were less hungry when taking six meals per day than with three, at an identical level of total calories. Read more
News • 15-9-2017

Cognitive behavioural group therapy does not help prevention weight regain after dieting in T2DM

EASD 2017 Two years after dieting, T2DM patients in a cognitive behavioural group therapy program showed similar weight regain and CV risk factors as those receiving standard care. Read more
News • 15-9-2017

New NHS device to help loose weight and improve glucose regulation in obese T2DM patients

EASD 2017 NHS provides the new, non-surgical, reversible weight loss Endobarrier device to help patients with poorly controlled T2DM and obesity kickstart a change in lifestyle. Read more
E-Learning •

What can be learned from the latest hypertension trials?

EPCCS 2017 Prof. Richard McManus summarises the results of three large trials that evaluated different intensities of blood pressure management and different blood pressure targets. With prof. Richard Hobbs, he considers what lessons can be learned for primary care. Read more
News • 10-9-2017

ESC GRAND DEBATE | Inflammation and cardiovascular disease

ESC 2017 One of the Grand Debates focused on different interpretations of the CANTOS trial data. Paul Ridker and Alberico Catapano debated how central inflammation is to CVD. Read more
News • 20-9-2017

EPCCS Practical Guidance on Heart Failure Diagnosis and Management in Primary Care

Based on the Heart Failure session and discussion during the 8th EPCCS Annual Meeting in Prague, this guidance document was written to help physicians diagnose and manage heart failure in their primary care practice. Read more
News • 15-9-2017

Women with diabetes show association between caffeine intake and lower risk of death

EASD 2017 In NHANES data, regularly drinking caffeinated coffee or tea was associated with lower mortality risk in women with diabetes, the protective effect varied with the source of caffeine. Read more
News • 15-9-2017

Risk factor management insufficient in transgender patients with diabetes

EASD 2017 Despite management by a multidisciplinary team, transgender persons with diabetes treated with hormones for gender confirmation had modifiable risk factors that aggravate diabetes. Read more

Statin treatment effective in pediatric patients with homozygous FH

13-9-2017 • Stein EA et al. J Am Coll Cardiol. 2017
In children and adolescents with HoFH, rosuvastatin 20 mg alone or in combination with ezetimibe and/or apheresis led to an effective LDL-C reduction, and was well tolerated. Read more
News • 10-9-2017

‘The lower the better’ even holds at very low achieved LDL-c

ESC 2017 FOURIER trial data show that after 2.2 years of follow-up, very low LDL-c levels are still associated with further reduction of CV events, without an increase in safety events. Read more
News • 10-9-2017

Reducing inflammation lowers CV events and possibly lung cancer rates

ESC 2017 Inhibition of IL-1β with canakinumab significantly lowered hsCRP levels and CV events, especially in those with higher than median CRP reduction, and incident lung cancer and lung cancer mortality were reduced. Read more

Upcoming meetings

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...